Table of Contents Table of Contents
Previous Page  12 / 56 Next Page
Information
Show Menu
Previous Page 12 / 56 Next Page
Page Background

12

|

BIOFORE

Bell concedes that the EUmarket

remains fragmented and is not

innovation-friendly enough. A large

number of Europe’s best researchers

and innovators are moving to

other continents in search of more

favourable conditions.

One of the disadvantages faced

by Europe is that land and energy

costs are lower and political support

and incentives are higher in its peer

countries. Europe is spending 0.8%

of GDP less than the US and 1.5% less

than Japan every year on Research &

Development (R&D).

“Our challenges are interconnected

and require effective action inmany

sectors. To unlock our potential

we need to increase research and

encourage more innovations in new

technologies”, emphasises Bell.

“We are putting much effort into

further developing bio-based products

like bio-plastics, bio-chemistry as

well as bio-basedmaterials, which

“The bio-based economy

is going to play a key role

in replacing fossil fuels

on a large scale, but this

is not just about energy.

We are also seeing new

emerging sectors, such

as biomaterials and

green chemistry.”

– John Bell.

The next industrial revolution

Europe is on a mission to lead the

bio-economic revolution. The

European bioeconomy is already a

major economic sector accounting

for nearly 18 million jobs in various

well-established bio-based industries

ranging from agriculture to forest-

based industries.

“The bio-based economy is going

to play a key role in replacing fossil

fuels on a large scale, but this is not just

about energy. We are also seeing new

emerging sectors, such as biomaterials

and green chemistry,” Bell says.

Accelerating development will

offer important opportunities for

innovation, jobs and growth, helping

Europe to ‘reindustrialise’. This task

requires expanding political awareness

of the need for a coherent framework to

promote investment in the bioeconomy

globally.

An increasing number of EU

Member States are creating their own

bioeconomy strategies. “More than

ever we need new sources of growth in

Europe. We can benefit economically

and environmentally frommaking

better use of our biological resources.

Our industry needs to fully exploit

the business opportunities that

will be created in the transition to

a sustainable economy.

“There are talented and visionary

people taking advantage of these

opportunities all over Europe. The

change is happening at a national

level but also many EU regions are

focused on launching their bioeconomy

strategies.”

Bio-breakthroughs big and small

Europe holds the biggest share

in the total number of industrial

biotechnology patent applications filed

since 2000. Although Europe leads the

field in innovation, it has not succeeded

in commercialising its technologies as

well as international competitors such

as the US, Brazil, China and South East

Asia.

John Bell